BioSpace News Archive

Acerus Pharmaceuticals Corporation announced that the Company has received a waiver letter from SWK Funding LLC related to the required Revenue Covenant for the third quarter of fiscal 2020 in its existing credit facility.

Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes, today announces that it has entered into a definitive agreement to acquire Holo Surgical Inc., (‘Holosurgical’)

Pfizer to invest $200 million in CStone shares and license CStone’s late-stage oncology asset sugemalimab (CS1001, PD-L1 antibody) in mainland China

DuraSorb ® Monofilament Mesh Earns CE Mark Approval Best-in-class soft tissue support product soon available in Europe for Abdominal Wall, Cosmetic, and Reconstructive Breast Procedures CHICAGO--( BUSINESS WIRE )-- Surgical Innovation Associates (SIA), an early growth-stage medical technology company, announced today it secured CE Mark approval for its flagship absorbable mesh, DuraSorb®. The product provides mechanical support and scaffolding during

HCPLive® and the American Lung Association Unveil Exclusive Interview with Anthony S. Fauci, M.D. Fauci calls for unified pandemic response, diverse representation in vaccine trials in a new podcast episode. CRANBURY, N.J.--( BUSINESS WIRE )-- HCPLive ®, in conjunction with the American Lung Association (ALA), has released an exclusive interview with Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, o

Sharecare, the digital health company that helps people manage all their health in one place, today announced that veteran healthcare executive Pam Shipley has joined the company as executive vice president and chief operating officer (COO).

MedinCell is a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO® technology with active ingredients already known and marketed.

Esperion (NASDAQ: ESPR) today announced the launch of “Break the Cycle with NEXLETOL”, a national direct-to-consumer (DTC) campaign aimed at broadening awareness of NEXLETOL® (bempedoic acid) Tablets and the never-ending patient cycle of diet, exercise and a statin treatment without ever reaching guideline recommended cholesterol levels.

PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations, today announced the closing of its initial public offering of 13,529,750 shares of common stock,

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will present a company update at the H.C. Wainwright 4th Annual NASH Investor Conference, being held virtually on October 5, 2020.